Patient demand and politics push Herceptin forward.
Kondro
Wayne
W
Sibbald
Barbara
B
D000911:Antibodies, Monoclonal / Q000191:economics / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000191:economics / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D002170:Canada; D004608:Eligibility Determination; D005260:Female; D006801:Humans; D009313:National Health Programs / Q000191:economics; D009362:Neoplasm Metastasis; D010358:Patient Participation; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis*; D000068878:Trastuzumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D018719:Erb-b2 Receptor Tyrosine Kinases; D000068878:Trastuzumab